Insider Transactions in Q2 2021 at Nrx Pharmaceuticals, Inc. (NRXP)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 24
2021
|
Alessandra Daigneault General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
6,320
+50.0%
|
-
|
|
May 24
2021
|
Patrick John Flynn |
BUY
Grant, award, or other acquisition
|
Indirect |
432,750
+50.0%
|
-
|
|
May 24
2021
|
Sharon Glied Director |
BUY
Grant, award, or other acquisition
|
Indirect |
13,168
+50.0%
|
-
|
|
May 24
2021
|
Aaron Gorovitz |
BUY
Grant, award, or other acquisition
|
Indirect |
41,686
+50.0%
|
-
|
|
May 24
2021
|
Chaim Hurvitz |
BUY
Grant, award, or other acquisition
|
Indirect |
1,644,793
+50.0%
|
-
|
|
May 24
2021
|
Daniel C. Javitt > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
13,971,864
+50.0%
|
-
|
|
May 24
2021
|
Jonathan C Javitt Chief Scientist |
BUY
Grant, award, or other acquisition
|
Indirect |
14,770,997
+50.0%
|
-
|
|
May 24
2021
|
Jonathan C Javitt Chief Scientist |
BUY
Grant, award, or other acquisition
|
Direct |
46,332
+50.0%
|
-
|
|
May 24
2021
|
Daniel Troy Director |
BUY
Grant, award, or other acquisition
|
Direct |
43,093
+50.0%
|
-
|
|
May 24
2021
|
Brac Lending Group LLC > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
869,565
-60.72%
|
-
|
|
May 24
2021
|
Big Rock Partners Sponsor, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
27,250
+4.99%
|
-
|
|
May 24
2021
|
Big Rock Partners Sponsor, LLC > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
5,435
-1.09%
|
-
|